Fox Rothschild LLP advised Prism Capital Partners on the deal. The global pharmaceutical company Eisai Inc. signed a long-term 332,818 s/f lease to relocate its North American…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
